These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15714966)

  • 1. [Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)'].
    Maeda O; Usami M
    Nihon Rinsho; 2005 Feb; 63(2):201-6. PubMed ID: 15714966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Summary and characteristics of 'General rule for clinical and pathological studies on prostate cancer (the 3rd edition)'].
    Murai M
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():39-43. PubMed ID: 12599542
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association.
    Cancer Registration Committee of the Japanese Urological Association
    Int J Urol; 2005 Jan; 12(1):46-61. PubMed ID: 15661054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological staging of prostate cancer].
    Tobisu K
    Nihon Rinsho; 2005 Feb; 63(2):225-30. PubMed ID: 15714970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostate cancer].
    Hinotsu S
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):620-3. PubMed ID: 20414018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
    Ito K
    Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A; Murai M; Baba S; Ogawa O; Tsukamoto T; Niwakawa M; Tobisu K; Kinukawa N; Naito S
    BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
    Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
    J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific antigen best practice statement: 2009 update.
    Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
    J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The assessment of pathological PSA values by the general practitioner--observation or intervention?].
    Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V
    Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU guidelines on prostate cancer.
    Aus G; Abbou CC; Bolla M; Heidenreich A; Schmid HP; van Poppel H; Wolff J; Zattoni F;
    Eur Urol; 2005 Oct; 48(4):546-51. PubMed ID: 16046052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection among men with prostate specific antigen levels of 2.5 to 4.0 ng/ml in a Japanese urological referral population.
    Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y
    J Urol; 2006 Apr; 175(4):1281-5. PubMed ID: 16515980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan.
    Ito K; Kakehi Y; Naito S; Okuyama A;
    Int J Urol; 2008 Sep; 15(9):763-8. PubMed ID: 18786203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
    Moul JW; Connelly RR; Lubeck DP; Bauer JJ; Sun L; Flanders SC; Grossfeld GD; Carroll PR
    J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of prostate cancer biochemical recurrence in the clinical guidelines].
    Fernández CH; Patiño GE; Merino RD; Chomón GB; Rios DS; Gárate MM; Gil MJ
    Arch Esp Urol; 2012; 65(1):79-83. PubMed ID: 22318179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of prostate-specific antigen in therapy follow-up of prostatic carcinoma].
    Wirth MP; Pilarsky C
    Urologe A; 1995 Jul; 34(4):297-302. PubMed ID: 7545844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
    Huland H; Hammerer P; Henke RP; Huland E
    J Urol; 1996 Apr; 155(4):1344-7. PubMed ID: 8632570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)].
    Tsuchiya N; Ohyama C; Habuchi T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):275-80. PubMed ID: 15751649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.